An anonymous donor has provided a sizable contribution to Indiana University of Pennsylvania's proposed college of ...

A Temple University student was shot and killed Thursday night, and another student has been taken into custody, according to ...

Virginia McCaskey, principal owner of the Chicago Bears and the only daughter of team founder George Halas, died Thursday at ...

The NCAA has changed its participation policy for transgender athletes, limiting competition in women’s sports to athletes ...

OpenAI is scouring the U.S. for sites to build a network of huge data centers to power its artificial intelligence technology ...

Lancaster Orthopedic Group has joined Penn State Health, expanding the latter’s orthopedic services across Lancaster and ...

FLASH radiation therapy could one day cure complex tumors and cancers while limiting the toll of radiation on the body. France's Institut Curie hopes to install one of the special machines in its ...

The Shapiro Administration will open a Multi-Agency Resource Center, or MARC, to help individuals, families, and businesses ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).